bpc-157 human trial case report The Hidden Risks of BPC‑157: What Patients Need to Know About Contamination and Safety If BPC-157 worked as well
Description
Light : UV and visible light accelerate oxidation and certain backbone cleavage reactions
It may be worth trying high dose oral/sublinguals in between injections - they can be effective for some patients - even those with PA - but don't help everyone
You can join PAS without having a PA diagnosis
This is especially common with larger or amphiphilic peptides
Currently, 38 peptide drugs are in phase III clinical trials
The remaining author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest
